Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy

ClinicalTrials.gov ID: NCT01049217

Public ClinicalTrials.gov record NCT01049217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of pregabalin compared to placebo in reducing neuropathic pain associated with HIV neuropathy.

Study identification

NCT ID
NCT01049217
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
377 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2010
Primary completion
Apr 30, 2012
Completion
Apr 30, 2012
Last update posted
Jan 27, 2021

2010 – 2012

United States locations

U.S. sites
25
U.S. states
8
U.S. cities
18
Facility City State ZIP Site status
Southwest Center for HIV/AIDS Phoenix Arizona 85006
SW Center for HIV/AIDS Phoenix Arizona 85006
Arizona Research Center Phoenix Arizona 85023
AIDS Research Alliance of America Los Angeles California 90015
Anthony Mills, MD, Inc. Los Angeles California 90069
David Geffen School of Medicine at UCLA c/o NNAB Los Angeles California 90095
Providence Clinical Research North Hollywood California 91606
Desert Medical Group, Inc. dba Desert Oasis Healthcare Medical Group Palm Springs California 92262
University of California San Diego San Diego California 92103
Stanford University Medical Center Stanford California 94305
Neuroscience Consultants, LLC. Aventura Florida 33180
South Florida Medical Research Aventura Florida 33180
The Kinder Medical Group Miami Florida 33133
Wohlfeiler, Piperato & Associates, LLC Miami Beach Florida 33139
Meridien Research Tampa Florida 33606
AIDS Research Consortium of Atlanta Atlanta Georgia 30308
Midtown Neurology, PC Atlanta Georgia 30312
Neurology Specialists of Decatur Research Center Decatur Georgia 30033
Rehabilitation Institute of Chicago Chicago Illinois 60611
Mount Sinai School of Medicine New York New York 10029
University of Toledo Medical Center Toledo Ohio 43614
University of Toledo Toledo Ohio 43614
University of Texas Physicians Bellaire Texas 77401
Amelia Court HIV Research Clinic Dallas Texas 75235
The University of Texas Medical School at Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01049217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2021 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01049217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →